Overexpression of FOXQ1 inhibited the senescence and improved the migration of human umbilical cord MSCs in vitro and in vivo, thus promoting their therapeutic efficacy in an animal model of Alzheimer's disease [37]. This evidence concerns the gene FOXQ1 and early-onset autosomal dominant Alzheimer disease.